4519

Chugai Pharmaceutical
4519

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
¥12.27T
EV
¥11.33T
Shares Outstanding
1.65B
Beta
0.66

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
¥8303.57
P/E 2025E
28.15x
P/Revenue 2025E
10.03x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Chugai Pharmaceutical Co., Ltd.

gainify
4519

Chugai Pharmaceutical Co., Ltd.

4519

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Found...

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Okuda, Osamu

Employees

5,026

IPO Date

2000-01-04

Headquarters

2-1-1 Nihonbashi-Muromachi, Chuo, Tokyo, 103-8324, Japan

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.